ABSTRACT
BACKGROUND Cardiovascular (CVD) risk factor reduction is a cornerstone of diabetes management. Here, we aimed to estimate the prevalence and determinants of individual and combined CVD risk factor control goals amongst individuals living with diagnosed diabetes in Mexico.
METHODS We analyzed Mexican National Health and Nutrition Surveys from 2016-2022 including individuals aged ≥20 years with diagnosed diabetes. We estimated the prevalence of glycemic, blood pressure, cholesterol, and smoking control, as well as combined control achievement according to current guidelines, as well as the prevalence of antihypertensive, statin and diabetes medication use. We also explored determinants of control achievement amongst individuals with diabetes using weighted logistic regression.
RESULTS We analyzed data from 2,331 adults with diagnosed diabetes. Glycemic control increased over time reaching 41% (95%CI 30%–52%) by 2022. Blood pressure control remained similar over time reaching 45% (95%CI 35%–55%) in 2022, LDL-C control remained low regardless of the definition (<70 vs. <100 mg/dL), whilst smoking control was high and increased over time to 92% (95%CI 88%–96%) in 2022. Combined risk factor control achievement was low, primarily due to suboptimal LDL-C control, despite a high proportion of medication use. Control achievement was more likely in Northern Mexico, in younger individuals, those with college education or living in states with lower social lag.
CONCLUSIONS Our results suggest a need to improve comprehensive glycemic and CVD risk factor management for individuals living with diabetes in Mexico to improve diabetes care and reduce risk of adverse outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data from ENSANUT can be accessed and downloaded at: https://ensanut.insp.mx/index.php
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
CONFLICT OF INTERESTS: The authors declare that they have no conflict of interests. 3,856 text words; 34 references; 3 figures, 2 tables.
DATA AVAILABILITY
All code and materials are available for reproducibility of results at https://github.com/oyaxbell/diabetescare_ensanut/
